{"id":"placebo-for-prednisolone","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo effect (perceived symptom improvement)"},{"rate":null,"effect":"Nocebo effect (perceived adverse events)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials. Any observed effects result from expectation, conditioning, and the patient-clinician relationship rather than direct drug action. In this Phase 3 trial context, the placebo serves as a comparator to assess the true efficacy of prednisolone, a corticosteroid.","oneSentence":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:24.110Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 clinical trial comparing prednisolone efficacy"}]},"trialDetails":[{"nctId":"NCT05139316","phase":"PHASE3","title":"A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)","status":"COMPLETED","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2021-11-08","conditions":"Glycogen Storage Disease Type IA","enrollment":49},{"nctId":"NCT07255248","phase":"PHASE4","title":"Hoffa's Fat Pad Impingement (HFPI)","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-03-01","conditions":"Hoffa's Fat Pad Impingement","enrollment":62},{"nctId":"NCT05435781","phase":"PHASE4","title":"Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency","status":"RECRUITING","sponsor":"Marianne Christina Klose","startDate":"2022-06-07","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis","enrollment":250},{"nctId":"NCT06585774","phase":"PHASE3","title":"A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2025-01-21","conditions":"Chronic Graft-versus-host-disease","enrollment":240},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT06624670","phase":"PHASE3","title":"A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-02-04","conditions":"Pyoderma Gangrenosum","enrollment":90},{"nctId":"NCT03644667","phase":"PHASE2","title":"Tocilizumab in Cardiac Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-12-20","conditions":"Heart Transplant","enrollment":385},{"nctId":"NCT05674994","phase":"PHASE3","title":"Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2023-10-26","conditions":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":110},{"nctId":"NCT03725202","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-01-24","conditions":"Giant Cell Arteritis (GCA)","enrollment":429},{"nctId":"NCT04161898","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2020-02-04","conditions":"Takayasu Arteritis (TAK)","enrollment":56},{"nctId":"NCT05345171","phase":"PHASE3","title":"Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2022-10-18","conditions":"OTC Deficiency","enrollment":32},{"nctId":"NCT04221477","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-08-10","conditions":"Lupus Nephritis","enrollment":271},{"nctId":"NCT04918147","phase":"PHASE2","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-10-13","conditions":"IgG4 Related Disease, IgG4-RD","enrollment":8},{"nctId":"NCT07380152","phase":"PHASE1","title":"Corticosteroid Therapy in Pulmonary Sequelae of Covid-19","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2021-08-10","conditions":"COVID-19 Pulmonary Complications","enrollment":100},{"nctId":"NCT07258771","phase":"PHASE4","title":"Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis","status":"RECRUITING","sponsor":"Berinstein, Jeffrey","startDate":"2026-01-16","conditions":"Ulcerative Colitis Acute","enrollment":110},{"nctId":"NCT04493853","phase":"PHASE3","title":"Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2020-07-13","conditions":"Hormone-Sensitive Prostate Cancer","enrollment":1012},{"nctId":"NCT07353749","phase":"PHASE4","title":"Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms","status":"NOT_YET_RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2026-01-30","conditions":"Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke","enrollment":864},{"nctId":"NCT06956482","phase":"PHASE3","title":"PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Alcoholic Hepatitis","enrollment":477},{"nctId":"NCT07348627","phase":"PHASE3","title":"Opioid-Sparing Joint Replacement","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Pain Management, Opioid Consumption","enrollment":120},{"nctId":"NCT05776459","phase":"PHASE2","title":"Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AudioCure Pharma GmbH","startDate":"2022-10-13","conditions":"Hearing Loss, Sensorineural","enrollment":210},{"nctId":"NCT05058287","phase":"PHASE3","title":"Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-11-05","conditions":"Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative","enrollment":150},{"nctId":"NCT05201469","phase":"PHASE2","title":"VIBRANT: VIB4920 for Active Lupus Nephritis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-05-16","conditions":"Lupus Nephritis","enrollment":74},{"nctId":"NCT07267650","phase":"NA","title":"iPACK Block vs. Periarticular Infiltration for TKA Pain Control","status":"NOT_YET_RECRUITING","sponsor":"Turgutlu State Hospital","startDate":"2026-01-01","conditions":"Pain, Postoperative, Osteoarthritis, Knee / Osteoarthritis, Hip","enrollment":100},{"nctId":"NCT07091175","phase":"PHASE2","title":"Dupilumab Therapy in Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-11-27","conditions":"Nephrotic Syndrome in Children, Nephrotic Syndrome Steroid-Dependent","enrollment":66},{"nctId":"NCT05643638","phase":"PHASE2","title":"A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD","status":"RECRUITING","sponsor":"Cynata Therapeutics Limited","startDate":"2024-03-04","conditions":"Graft Versus Host Disease, Acute","enrollment":60},{"nctId":"NCT05190770","phase":"PHASE2","title":"A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-12-15","conditions":"Breast Cancer, Breast Cancer Stage, Breast Cancer Stage I","enrollment":18},{"nctId":"NCT06360458","phase":"PHASE3","title":"Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wan-Jin Chen","startDate":"2024-08-01","conditions":"Acute Ischemic Stroke, Large Infarct Core","enrollment":928},{"nctId":"NCT07252271","phase":"PHASE4","title":"Very Low Dose Prednisolone on Newly Diagnosed Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-12-01","conditions":"Rhematoid Arthritis","enrollment":112},{"nctId":"NCT04701034","phase":"PHASE2","title":"Intravenous Immunoglobulin and Prednisolone for RPL After ART.","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2021-01-28","conditions":"Habitual Abortion, Recurrent Pregnancy Loss, Fertility Disorders","enrollment":80},{"nctId":"NCT02433522","phase":"PHASE3","title":"Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-03-31","conditions":"ANCA-associated Vasculitides","enrollment":97},{"nctId":"NCT06298383","phase":"NA","title":"The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-06-15","conditions":"Symptomatic Irreversible Pulpitis","enrollment":120},{"nctId":"NCT06841705","phase":"PHASE2","title":"Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial","status":"RECRUITING","sponsor":"Shilpa Grover, MD, MPH","startDate":"2025-07-15","conditions":"Immune Checkpoint Inhibitor-Related Colitis","enrollment":80},{"nctId":"NCT04843761","phase":"PHASE3","title":"ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-04-20","conditions":"Covid19","enrollment":473},{"nctId":"NCT03584516","phase":"PHASE2, PHASE3","title":"GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2019-01-17","conditions":"Chronic Graft-versus-host Disease","enrollment":155},{"nctId":"NCT06729593","phase":"PHASE3","title":"Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-04-20","conditions":"Covid19","enrollment":87},{"nctId":"NCT06729606","phase":"PHASE3","title":"Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-04-20","conditions":"Covid19","enrollment":471},{"nctId":"NCT07202143","phase":"PHASE3","title":"Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia","status":"RECRUITING","sponsor":"YiLin","startDate":"2025-09-01","conditions":"Large Infarct Core, Post-stroke Lymphocytopenia","enrollment":200},{"nctId":"NCT07141303","phase":"PHASE3","title":"Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-08-08","conditions":"Acute Ischemic Stroke","enrollment":1060},{"nctId":"NCT07180277","phase":"PHASE4","title":"Methylprednisolone for Moderate to Severe Traumatic Brain Injury","status":"NOT_YET_RECRUITING","sponsor":"Zhangjiagang First People's Hospital","startDate":"2025-10-01","conditions":"Traumatic Brain Injury","enrollment":520},{"nctId":"NCT07175649","phase":"NA","title":"Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-10","conditions":"Ischemic Stroke, Acute","enrollment":912},{"nctId":"NCT00804531","phase":"PHASE4","title":"Intra-discal Steroid Injection for MODIC I Discopathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-04","conditions":"Back Pain Lower Back Chronic","enrollment":137},{"nctId":"NCT03775460","phase":"NA","title":"Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum","status":"ACTIVE_NOT_RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2023-01-15","conditions":"Erythema Nodosum Leprosum","enrollment":550},{"nctId":"NCT04824092","phase":"PHASE3","title":"Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incyte Corporation","startDate":"2021-05-11","conditions":"Diffuse Large B-cell Lymphoma","enrollment":899},{"nctId":"NCT03139604","phase":"PHASE3","title":"GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2017-07-19","conditions":"Graft-versus-host Disease (GVHD)","enrollment":439},{"nctId":"NCT06446245","phase":"PHASE2","title":"Adjunctive Doxycycline for Central Nervous System Tuberculosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-08-21","conditions":"Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology), Tuberculosis, Central Nervous System","enrollment":200},{"nctId":"NCT06471465","phase":"PHASE3","title":"Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases","status":"RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2025-04-29","conditions":"Radionecrosis of Brain, Brain Metastases","enrollment":84},{"nctId":"NCT07116811","phase":"PHASE3","title":"Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-01","conditions":"Vestibular Schwannoma, Facial Nerve Paralysis","enrollment":364},{"nctId":"NCT07112456","phase":"PHASE2","title":"Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-09-01","conditions":"Asthma Acute, Asthma Attack, Asthma Exacerbations","enrollment":100},{"nctId":"NCT05150704","phase":"PHASE3","title":"MYTHS - MYocarditis THerapy With Steroids","status":"RECRUITING","sponsor":"Niguarda Hospital","startDate":"2021-10-07","conditions":"Myocarditis Acute","enrollment":288},{"nctId":"NCT05570409","phase":"PHASE2, PHASE3","title":"Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy","status":"TERMINATED","sponsor":"LMU Klinikum","startDate":"2023-03-28","conditions":"Inflammatory Cardiomyopathy","enrollment":9},{"nctId":"NCT05288166","phase":"PHASE3","title":"A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2022-04-14","conditions":"Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms","enrollment":925},{"nctId":"NCT04921189","phase":"PHASE2","title":"Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2021-12-31","conditions":"Out-Of-Hospital Cardiac Arrest, Postcardiac Arrest Syndrome","enrollment":160},{"nctId":"NCT05436652","phase":"PHASE2","title":"A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)","status":"COMPLETED","sponsor":"Sparrow Pharmaceuticals","startDate":"2022-07-22","conditions":"Polymyalgia Rheumatica","enrollment":66},{"nctId":"NCT05097976","phase":"PHASE4","title":"Medrol Dosepak for Outpatient Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2022-03-01","conditions":"Total Knee Arthroplasty","enrollment":420},{"nctId":"NCT05698680","phase":"PHASE4","title":"Prednisolone Versus Colchicine for Acute Gout in Primary Care","status":"RECRUITING","sponsor":"University Medicine Greifswald","startDate":"2023-01-18","conditions":"Acute Gout","enrollment":314},{"nctId":"NCT05974462","phase":"PHASE3","title":"MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2024-05-24","conditions":"Acute Myocarditis","enrollment":174},{"nctId":"NCT06925698","phase":"PHASE3","title":"Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2025-04-30","conditions":"Behcet Disease, Behcet Disease and Vascular Involvement, Deep Venous Thromboses","enrollment":110},{"nctId":"NCT06917859","phase":"PHASE1","title":"Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-02-01","conditions":"Cardiopulmonary Bypass, AKI - Acute Kidney Injury","enrollment":170},{"nctId":"NCT02288247","phase":"PHASE3","title":"A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone","status":"COMPLETED","sponsor":"Astellas Pharma Europe Ltd.","startDate":"2014-12-01","conditions":"Metastatic Castration Resistant Prostate Cancer","enrollment":688},{"nctId":"NCT06035081","phase":"NA","title":"CIRcadian Rhythms and CortisoL. Effects on Substrate Metabolism and Clock Gene Expression and Functioning","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2023-09-15","conditions":"Healthy","enrollment":10},{"nctId":"NCT05638633","phase":"PHASE3","title":"Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2022-11-11","conditions":"Post-COVID-19 Syndrome","enrollment":321},{"nctId":"NCT02785224","phase":"","title":"Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.","status":"WITHDRAWN","sponsor":"University of Athens","startDate":"2025-12","conditions":"Cardiac Arrest","enrollment":""},{"nctId":"NCT02004782","phase":"PHASE4","title":"Barretts oEsophageal Resection With Steroid Therapy Trial","status":"WITHDRAWN","sponsor":"Professor Michael Bourke","startDate":"2020-03-09","conditions":"Barrett Esophagus, Esophageal Stenosis","enrollment":""},{"nctId":"NCT06896253","phase":"PHASE2","title":"Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04","conditions":"Myocarditis Acute","enrollment":120},{"nctId":"NCT06870448","phase":"PHASE3","title":"Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-04","conditions":"Acute Ischemic Stroke","enrollment":1614},{"nctId":"NCT05986422","phase":"PHASE2","title":"Methylprednisolone in Patients with Cognitive Deficits in Post-COVID-19 Syndrome (PCS)","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2023-10-01","conditions":"Post-COVID-19 Syndrome","enrollment":418},{"nctId":"NCT02043678","phase":"PHASE3","title":"Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-03-30","conditions":"Prostatic Neoplasms","enrollment":806},{"nctId":"NCT05444699","phase":"PHASE4","title":"Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age","status":"RECRUITING","sponsor":"University of Oulu","startDate":"2022-10-11","conditions":"Bronchiolitis Acute Viral","enrollment":210},{"nctId":"NCT04072822","phase":"PHASE2","title":"Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-07-10","conditions":"Alcoholic Hepatitis","enrollment":147},{"nctId":"NCT06623370","phase":"PHASE4","title":"The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group","status":"COMPLETED","sponsor":"Konya City Hospital","startDate":"2024-10-01","conditions":"Sugammadex Reversal Time, Muscle Weakness","enrollment":80},{"nctId":"NCT06472219","phase":"PHASE3","title":"PREDICATE Trial For Respiratory Tract Infections","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2024-12-23","conditions":"Respiratory Tract Infections","enrollment":1300},{"nctId":"NCT06762145","phase":"PHASE4","title":"EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)","status":"NOT_YET_RECRUITING","sponsor":"Xiao-dong Zhuang","startDate":"2025-01-01","conditions":"Transcatheter Aortic Valve Replacemen, Left Bundle Branch Block","enrollment":200},{"nctId":"NCT06453083","phase":"EARLY_PHASE1","title":"Medrol Dose Packs for Post-Operative Pain Control","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-01-13","conditions":"Pain","enrollment":57},{"nctId":"NCT02631603","phase":"PHASE2","title":"Stop Exogenous Allergic Alveolitis (EAA) in Childhood","status":"TERMINATED","sponsor":"Matthias Griese","startDate":"2015-04","conditions":"Hypersensitivity Pneumonitis, Exogenous Allergic Alveolitis","enrollment":4},{"nctId":"NCT02626455","phase":"PHASE3","title":"Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)","status":"TERMINATED","sponsor":"Bayer","startDate":"2016-01-06","conditions":"Lymphoma, Non-Hodgkin","enrollment":551},{"nctId":"NCT02196155","phase":"NA","title":"Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2016-07","conditions":"Plantar Fasciitis","enrollment":54},{"nctId":"NCT04826237","phase":"PHASE4","title":"Oral Statins and Protection From Hearing Loss","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2023-02-09","conditions":"Sudden Sensorineural Hearing Loss","enrollment":100},{"nctId":"NCT06421597","phase":"PHASE2","title":"Identifying Individuals At Risk of Glucocorticoid-Induced Impairment of Bone Disease","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-11-04","conditions":"Osteoporosis Secondary","enrollment":36},{"nctId":"NCT04323566","phase":"PHASE2","title":"Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement","status":"ENROLLING_BY_INVITATION","sponsor":"Uppsala University Hospital","startDate":"2022-05-01","conditions":"Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior, Schizophrenia","enrollment":40},{"nctId":"NCT06670521","phase":"PHASE2","title":"Corticosteroids for Post-Extubation Dysphagia","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-11-13","conditions":"Dysphagia, Laryngeal Edema","enrollment":80},{"nctId":"NCT03418779","phase":"PHASE2, PHASE3","title":"Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-07-04","conditions":"IgA Nephropathy at High Risk of Developing ESRD","enrollment":60},{"nctId":"NCT02550652","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2015-11-13","conditions":"Lupus Nephritis","enrollment":126},{"nctId":"NCT00092989","phase":"PHASE3","title":"Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-07","conditions":"Asthma","enrollment":650},{"nctId":"NCT05720715","phase":"PHASE4","title":"Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis","status":"COMPLETED","sponsor":"Farwaniya Hospital","startDate":"2022-01-01","conditions":"Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis","enrollment":30},{"nctId":"NCT06522100","phase":"PHASE3","title":"Corticoid Therapy in Acute Myocarditis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-01","conditions":"Acute Myocarditis","enrollment":420},{"nctId":"NCT04556760","phase":"PHASE2","title":"Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-11-26","conditions":"Diabetes Mellitus, Type 2","enrollment":46},{"nctId":"NCT03994731","phase":"PHASE4","title":"Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout","status":"COMPLETED","sponsor":"Amgen","startDate":"2019-06-13","conditions":"Gout","enrollment":152},{"nctId":"NCT05725512","phase":"PHASE4","title":"Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2024-01-29","conditions":"Recurrent Miscarriage, Recurrent Pregnancy Loss, Habitual Abortion","enrollment":490},{"nctId":"NCT04014634","phase":"PHASE4","title":"GON-injection for a Sooner and Better Treatment of Cluster Headache","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2019-08-01","conditions":"Cluster Headache, Episodic, Greater Occipital Nerve Injection","enrollment":70},{"nctId":"NCT03298061","phase":"PHASE3","title":"Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-04-14","conditions":"Churg-Strauss Syndrome, Eosinophilic Granulomatosis With Polyangiitis","enrollment":100},{"nctId":"NCT03355482","phase":"PHASE2","title":"MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE","status":"TERMINATED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2017-04-10","conditions":"Systemic Lupus Erythematosus Arthritis","enrollment":9},{"nctId":"NCT06266221","phase":"PHASE3","title":"Severe Erythema Multiforme - CORTICO","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-05-01","conditions":"Erythema Multiforme","enrollment":96},{"nctId":"NCT04051203","phase":"PHASE1","title":"Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2019-02-01","conditions":"Occipital Neuralgia, Headache","enrollment":35},{"nctId":"NCT03484507","phase":"PHASE2","title":"Parasitic Ulcer Treatment Trial Pilot","status":"UNKNOWN","sponsor":"University of California, San Francisco","startDate":"2018-01-01","conditions":"Acanthamoeba Keratitis","enrollment":49},{"nctId":"NCT03752307","phase":"PHASE1, PHASE2","title":"Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2019-02-15","conditions":"Multiple Sclerosis","enrollment":2},{"nctId":"NCT06236152","phase":"NA","title":"Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis","status":"COMPLETED","sponsor":"Fahad Javed Awan","startDate":"2022-07-01","conditions":"Tuberculous Lymphadenitis, Cervical","enrollment":140},{"nctId":"NCT04098718","phase":"PHASE2","title":"Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2021-03-29","conditions":"Asthma, COPD","enrollment":158},{"nctId":"NCT03371667","phase":"PHASE3","title":"To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-08-16","conditions":"Allogeneic Disease, GVH - Graft Versus Host Reaction, GVHD, Acute","enrollment":102},{"nctId":"NCT06198894","phase":"NA","title":"Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms","status":"RECRUITING","sponsor":"Zheng Liu","startDate":"2024-01-10","conditions":"Chronic Sinusitis","enrollment":96},{"nctId":"NCT03371498","phase":"PHASE3","title":"Procollagen-3 Driven Corticosteroids for Persistent Acute Respiratory Distress Syndrome","status":"TERMINATED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2018-12-27","conditions":"Persistent ARDS","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1193,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo (for Prednisolone)","genericName":"Placebo (for Prednisolone)","companyName":"Prof. Dominique de Quervain, MD","companyId":"prof-dominique-de-quervain-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control arm in Phase 3 clinical trial comparing prednisolone efficacy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}